Continuous Infusion of N-acetylcysteine Reduces Liver Warm Ischaemia-reperfusion Injury
Overview
Affiliations
Background: N-acetylcysteine (NAC) may modulate the initial phase (less than 2 h) of liver warm ischaemia-reperfusion (IR) injury but its effect on the late phase remains unclear. The present study investigated the role of NAC during the early and late phases in a rabbit lobar IR model.
Methods: Liver ischaemia was induced by inflow occlusion to the median and left liver lobes for 60 min, followed by 7 h of reperfusion. In the NAC group (n = 6), NAC was administered intravenously at 150 mg per kg over the 15 min before reperfusion and maintained at 10 mg per kg per h during reperfusion. In the IR group (n = 6), 20 ml 5 per cent dextrose was infused over the 15 min before reperfusion and continued at a rate of 10 ml/h. Animals in a sham operation group (n = 6) underwent laparotomy but no liver ischaemia. All animals were killed at the end of the experiment.
Results: Intracellular tissue oxygenation was improved after the second hour of reperfusion in animals treated with NAC compared with that in the IR group (P = 0.023). Hepatic microcirculation improved after 5 h of reperfusion (P = 0.036) and liver injury was reduced after 5 h, as indicated by alanine aminotransferase activity (P = 0.007) and indocyanine green clearance (uptake, P = 0.001; excretion, P = 0.032).
Conclusion: The main protective effect of NAC becomes apparent 5 h after hepatic ischaemic injury.
Mantelou A, Zacharioudaki A, Pappas-Gogos G, Papalois A, Papoudou-Bai A, Goussia A In Vivo. 2022; 36(1):153-160.
PMID: 34972710 PMC: 8765142. DOI: 10.21873/invivo.12686.
Masior L, Grat M Int J Mol Sci. 2021; 22(15).
PMID: 34360995 PMC: 8347959. DOI: 10.3390/ijms22158229.
Use of natural anti-oxidants in experimental animal models of hepatic ischemia-reperfusion injury.
Kyriakopoulos G, Valsami G, Tsalikidis C, Pitiakoudis M, Tsaroucha A Ann Med Surg (Lond). 2020; 60:592-599.
PMID: 33304570 PMC: 7708685. DOI: 10.1016/j.amsu.2020.11.061.
Jegatheeswaran S, Jamdar S, Satyadas T, Sheen A, Adam R, Siriwardena A HPB Surg. 2014; 2014:437159.
PMID: 25477707 PMC: 4244917. DOI: 10.1155/2014/437159.
N-acetylcysteine administration does not improve patient outcome after liver resection.
Robinson S, Saif R, Sen G, French J, Jaques B, Charnley R HPB (Oxford). 2013; 15(6):457-62.
PMID: 23458723 PMC: 3664050. DOI: 10.1111/hpb.12005.